Espirito Santo has downgraded Bangalore-based Biocon to "sell" from "neutral" and sharply revised its target price to Rs 186 a share from Rs 350, flagging off several issues, which it says raise accounting and corporate governance questions over at the biotech firm. The investment bank points out to two issues in particular. The latest being Pfizer scrapping a deal to sell insulin products made by Biocon. Changed priorities at Pfizer...
12:10 PM, May 22, 2012
New Delhi: Biocon and US drug major Pfizer on Tuesday called off $350 million global alliance to commercialise the Bangalore-based firm's biosimilar versions of insulin and insulin analog products. "The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently," the two said in a joint statement. In October 2010, they entered into a strategic global...
12:08 PM, Mar 13, 2012
Bangalore: Call it the Saturday night fever, but all for a good cause when nine jet-setting CEOs from corporate India lent their voice to a charity event, suitably titled 'CEOs sing for their supper'. But for Biocon founder and MD, Kiran Mazumdar Shaw, the exercise was pure passion singing. "I don't think I'm singing for my supper as I'm on a diet but am singing for these kids who need ...
07:46 AM, Jul 17, 2011
Bangalore: Call it the Saturday night fever, but all for a good cause when nine jet-setting CEOs from corporate India lent their voice to a charity event, suitably titled 'CEOs sing for their supper'. But for Biocon founder and MD, Kiran Mazumdar Shaw, the exercise was pure passion singing. "I don't think I'm singing for my supper as I'm on a diet but am singing for these kids who need...
07:46 AM, Jul 17, 2011
Villagers allege it has polluted air and ground water in the Hebbagodi region. ...
03:58 PM, Dec 02, 2008
New Delhi: Pakistan spinner Saeed Ajmal's controversial bowling action has sparked off a heated debate with some Indian greats calling him an outright chucker but their counterparts across the border have backed him to the hilt. While former spinners like Bishan Singh Bedi, Erapalli Prasanna and Maninder Singh have questioned the legality of his action, Pakistani players like Abdul Qadir and Saqlain Mushtaq and senior Indian offspinner Harbhajan Singh have...
08:22 PM, Apr 22, 2008
Biocon has entered into partnership with Bristol-Myers Squibb to provide research for development of drugs. ...
09:43 PM, Mar 14, 2007
After launching a drug for solid tumours, India's leading biotech firm Biocon will launch a new anti-arthritis drug. ...
10:34 AM, Nov 28, 2006
Biocon has unveiled BIOMAb-EGFR, a therapeutic antibody-based drug for treating tumours of epithelial origin. ...
09:45 AM, Sep 19, 2006
Infosys Q2 profit up | Infosys declares 200 pc dividend ...
displayed with permission. Use of the CNN name and/or logo on or as part of CNN-IBN does not derogate from the intellectual property rights of Cable News Network in respect of them.
Disclaimer: Network18 Media & Investments Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
Disclaimer: TV18 Broadcast Limited is proposing, subject to market conditions and other considerations, an offer of its equity shares on rights basis and has filed a Draft Letter of Offer with the Securities and Exchange Board of India. The Draft Letter of Offer is available on the website of SEBI at www.sebi.gov.in and the websites of the Lead Managers at www.icicisecurities.com and www.rbs.in Investors should note that investment in equity shares involves a high degree of risk and are requested to refer to "Risk Factors" in the Draft Letter of Offer. The Equity Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or any state securities laws in the United States and may not be offered or sold in the United States or to, or for the account or benefit of, "U.S. persons" (as defined in Regulation S under the US Securities Act) except in a transaction exempt from the registration requirements of the US Securities Act and in accordance with any applicable U.S. state securities laws.
